Avanos Medical, Inc.
AVNS
$13.11
-$0.01-0.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.30M | -1.40M | -76.80M | 6.60M | -397.30M |
| Total Depreciation and Amortization | 9.90M | 9.40M | 10.00M | 9.60M | 11.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.90M | 8.90M | 80.40M | 4.10M | 399.10M |
| Change in Net Operating Assets | 24.50M | -2.90M | -6.80M | 5.40M | 45.00M |
| Cash from Operations | 28.20M | 14.00M | 6.80M | 25.70M | 57.90M |
| Capital Expenditure | -6.90M | -7.00M | -11.00M | -6.70M | -4.80M |
| Sale of Property, Plant, and Equipment | 0.00 | 4.00M | -- | -- | -- |
| Cash Acquisitions | 300.00K | -28.30M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -2.10M |
| Other Investing Activities | -200.00K | -200.00K | -2.20M | -2.40M | -700.00K |
| Cash from Investing | -6.80M | -31.50M | -13.20M | -9.10M | -7.60M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -2.40M | -2.30M | -2.40M | -27.30M | -27.30M |
| Issuance of Common Stock | 0.00 | 300.00K | 0.00 | 400.00K | 0.00 |
| Repurchase of Common Stock | -300.00K | 0.00 | -800.00K | -2.20M | -100.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -2.70M | -2.00M | -3.20M | -29.10M | -27.40M |
| Foreign Exchange rate Adjustments | 600.00K | -300.00K | 2.90M | 1.80M | -4.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.30M | -19.80M | -6.70M | -10.70M | 18.70M |